This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Stéphane Poirier
Introduction
Stéphane Poirier is a notable inventor based in Stoneham, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His work has led to the development of innovative combinations of therapeutic agents.
Latest Patents
Stéphane Poirier holds a patent for a combination comprising alpelisib and 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid. This patent outlines a pharmaceutical composition that includes this combination and its therapeutic uses, especially for treating cancer, including breast cancer. He has 1 patent to his name.
Career Highlights
Stéphane Poirier is currently employed at Sanofi, a leading global healthcare company. His role involves research and development in the pharmaceutical sector, focusing on innovative treatments for various diseases.
Collaborations
He has collaborated with notable colleagues such as Monsif Bouaboula and Zhuyan Guo. Their teamwork has contributed to advancements in the pharmaceutical field.
Conclusion
Stéphane Poirier's work exemplifies the impact of innovation in healthcare, particularly in cancer treatment. His contributions continue to influence the development of effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile